(Q41181725)

27 September 2017

1 reference

title

Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose (English)

1 reference

27 September 2017

1 reference

Cullen LK

1

1 reference

27 September 2017

publication date

1 September 1996

1 reference

27 September 2017

published in

The Veterinary Journal

1 reference

27 September 2017

volume

152

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

519-535

1 reference

α 2 -Adrenoceptor-Mediated Hyperpolarization of Locus Coeruleus Neurons: Intracellular Studies in Vivo

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Adrenergic-induced hyperglycemia in anaesthetized rats: involvement of peripheral alpha 2-adrenoceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Duration of analgesia induced by epidurally administered morphine and medetomidine in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Emetic action of xylazine on the chemoreceptor trigger zone for vomiting in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Xylazine or medetomidine premedication before propofol anaesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Alpha 2 adrenoceptor agonists and anaesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

The role of central adrenoreceptors in the control of vasopressin release and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effects of medetomidine on intestinal and colonic motility in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Interaction Between Opiate Subtype and Alpha-2 Adrenergic Agonists in Suppression of Noxiously Evoked Activity of WDR Neurons in the Spinal Dorsal Horn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Distribution of alpha 2-adrenergic receptors in the human brainstem: an autoradiographic study using [3H]p-aminoclonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

The Effects of the Stereoisomers of the α2-Adrenergic Agonist Medetomidine on Systemic and Coronary Hemodynamics in Conscious Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Circulatory and respiratory effects of the combination medetomidine-ketamine in beagles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Sedative action of the alpha 2-agonist medetomidine in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Reversal of medetomidine sedation by atipamezole in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Sedative and analgesic effects of medetomidine in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Medetomidine-butorphanol-midazolam for anaesthesia in dogs and its reversal by atipamezole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

An evaluation of medetomidine/ketamine and other drug combinations for anaesthesia in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Antagonistic activities of atipamezole, 4-aminopyridine and yohimbine against medetomidine/ketamine-induced anaesthesia in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980005-4

10.1016/S0007-1935(96)80005-4

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference